{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:40:31Z","timestamp":1770882031303,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Dutch Research Agenda (NWA) given by the Dutch Research Council"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Over the past decade opioid use has risen globally. The causes and consequences of this increase, especially in Europe, are poorly understood. We conducted a population-based cohort study using national statistics on analgesics prescriptions, opioid poisoning hospital admissions and deaths in the Netherlands from 2013 to 2017. Pain prevalence and severity was determined by using results of 2014\u20132017 Health Interview Surveys. Between 2013 and 2017 the proportion of residents receiving opioid prescription rose from 4.9% to 6.0%, and the proportion of those receiving NSAIDs decreased from 15.5% to 13.7%. Self-reported pain prevalence and severity remained constant, as 44.7% of 5,119 respondents reported no pain-impeded activities-of-daily-living in 2014 (aRR, 1.00 [95% CI, 0.95\u20131.06] in 2017 vs 2014). Over the observation period, the incidence of opioid poisoning hospitalization and death increased from 8.6 to 12.9 per 100,000 inhabitants. The incidence of severe outcomes related to opioid use increased, as 3.9% of 1,343 hospitalized for opioid poisoning died in 2013 and 4.6% of 2,055 in 2017. We demonstrated that NSAIDs prescription decreased and opioid prescription increased in the Netherlands since 2013, without an increase in pain prevalence and severity. Consequently, the incidence of severe outcomes related to opioids increased.\n<\/jats:p>","DOI":"10.1038\/s41598-020-72084-6","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T21:28:45Z","timestamp":1600378125000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Causes and consequences of the opioid epidemic in the Netherlands: a population-based cohort study"],"prefix":"10.1038","volume":"10","author":[{"given":"Ajda","family":"Bedene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveline L. A.","family":"van Dorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Faquih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanna C.","family":"Cannegieter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis O.","family":"Mook-Kanamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieke","family":"Niesters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"van Velzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maaike G. J.","family":"Gademan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frits R.","family":"Rosendaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel L.","family":"Bouvy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem M.","family":"Lijfering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"72084_CR1","unstructured":"Stichting Farmaceutische Kengetallen (SFK). Aantal oxycodon-gebruikers in drie jaar tijd verdubbeld. Pharmaceutisch Weekblad 151 (2016)."},{"key":"72084_CR2","doi-asserted-by":"publisher","first-page":"e1910223","DOI":"10.1001\/jamanetworkopen.2019.10223","volume":"2","author":"A Bedene","year":"2019","unstructured":"Bedene, A. et al. Opioid prescription patterns and risk factors associated with opioid use in the Netherlands. JAMA Netw. Open 2, e1910223. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.10223 (2019).","journal-title":"JAMA Netw. Open"},{"key":"72084_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.jpain.2015.05.002","volume":"16","author":"RL Nahin","year":"2015","unstructured":"Nahin, R. L. Estimates of pain prevalence and severity in adults: United States, 2012. J. Pain 16, 769\u2013780. https:\/\/doi.org\/10.1016\/j.jpain.2015.05.002 (2015).","journal-title":"J. Pain"},{"key":"72084_CR4","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1016\/j.pain.2013.07.029","volume":"154","author":"KV Patel","year":"2013","unstructured":"Patel, K. V., Guralnik, J. M., Dansie, E. J. & Turk, D. C. Prevalence and impact of pain among older adults in the United States: Findings from the 2011 National Health and Aging Trends Study. Pain 154, 2649\u20132657. https:\/\/doi.org\/10.1016\/j.pain.2013.07.029 (2013).","journal-title":"Pain"},{"key":"72084_CR5","doi-asserted-by":"publisher","first-page":"15078","DOI":"10.1073\/pnas.1518393112","volume":"112","author":"A Case","year":"2015","unstructured":"Case, A. & Deaton, A. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc. Natl. Acad. Sci. USA 112, 15078\u201315083. https:\/\/doi.org\/10.1073\/pnas.1518393112 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"Suppl 3","key":"72084_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/ar4175","volume":"15","author":"C Sostres","year":"2013","unstructured":"Sostres, C., Gargallo, C. J. & Lanas, A. Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage. Arthritis Res Ther 15(Suppl 3), 3. https:\/\/doi.org\/10.1186\/ar4175 (2013).","journal-title":"Arthritis Res Ther"},{"key":"72084_CR7","doi-asserted-by":"publisher","first-page":"j1909","DOI":"10.1136\/bmj.j1909","volume":"357","author":"M Bally","year":"2017","unstructured":"Bally, M. et al. Risk of acute myocardial infarction with NSAIDs in real world use: Bayesian meta-analysis of individual patient data. BMJ 357, j1909. https:\/\/doi.org\/10.1136\/bmj.j1909 (2017).","journal-title":"BMJ"},{"key":"72084_CR8","first-page":"A7005","volume":"157","author":"PL Houweling","year":"2013","unstructured":"Houweling, P. L. et al. Herziene richtlijn \u2018Postoperatieve pijn\u2019. Ned. Tijdschr. Geneeskd. 157, A7005-7009 (2013).","journal-title":"Ned. Tijdschr. Geneeskd."},{"key":"72084_CR9","unstructured":"Stichting Farmaceutische Kengetallen (SFK). 400.000 NSAID-gebruikers minder dan tien jaar geleden. Pharmaceutisch Weekblad 153 (2018)."},{"key":"72084_CR10","first-page":"ES9-38","volume":"15","author":"L Manchikanti","year":"2012","unstructured":"Manchikanti, L. et al. Opioid epidemic in the United States. Pain Physician 15, ES9-38 (2012).","journal-title":"Pain Physician"},{"key":"72084_CR11","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1213\/ane.0000000000002388","volume":"125","author":"DJ Clark","year":"2017","unstructured":"Clark, D. J. & Schumacher, M. A. America\u2019s opioid epidemic: Supply and demand considerations. Anesth. Analg. 125, 1667\u20131674. https:\/\/doi.org\/10.1213\/ane.0000000000002388 (2017).","journal-title":"Anesth. Analg."},{"key":"72084_CR12","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","volume":"65","author":"RA Rudd","year":"2016","unstructured":"Rudd, R. A., Seth, P., David, F. & Scholl, L. Increases in drug and opioid-involved overdose deaths\u2014United States, 2010\u20132015. MMWR Morb. Mortal. Wkly. Rep. 65, 1445\u20131452. https:\/\/doi.org\/10.15585\/mmwr.mm655051e1 (2016).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"72084_CR13","unstructured":"Centraal Bureau voor de Statistiek (CBS). Documentatie Persoonskenmerken van alle in de Gemeentelijke Basis Administratie (GBA) ingeschreven personen, geco\u00f6rdineerd (GBAPERSOONTAB), https:\/\/www.cbs.nl\/-\/media\/cbs%20op%20maat\/microdatabestanden\/documents\/2019\/27\/gbapersoontab.pdf (2019)."},{"key":"72084_CR14","unstructured":"Centraal Bureau voor de Statistiek (CBS). Documentatie Verstrekkingen van geneesmiddelen op 4 posities ATC code aan personen (MEDICIJNTAB), https:\/\/www.cbs.nl\/-\/media\/cbs%20op%20maat\/microdatabestanden\/documents\/2019\/15\/medicijntab.pdf (2019)."},{"key":"72084_CR15","unstructured":"Landelijke Basisregistratie Ziekenhuiszorg (LBZ). Gebruikershandleiding Landelijke Basisregistratie Ziekenhuiszorg (LBZ), https:\/\/www.dhd.nl\/klantenservice\/handleidingen_formulieren\/documents\/Gebruikershandleiding%20Landelijke%20Basisregistratie%20Ziekenhuiszorg%20%28LBZ%29.pdf (2018)."},{"key":"72084_CR16","unstructured":"Centraal Bureau voor de Statistiek (CBS). Documentatie Doodsoorzaken van personen die bij overlijden inwoners waren van Nederland (DOODOORZTAB), https:\/\/www.cbs.nl\/-\/media\/cbs%20op%20maat\/microdatabestanden\/documents\/2019\/42\/doodoorztab.pdf (2019)."},{"key":"72084_CR17","unstructured":"Centraal Bureau voor de Statistiek (CBS). Gezondheidsenqu\u00eate vanaf 2014, https:\/\/www.cbs.nl\/nl-nl\/onze-diensten\/methoden\/onderzoeksomschrijvingen\/korte-onderzoeksbeschrijvingen\/gezondheidsenquete-vanaf-2014 (2019)."},{"key":"72084_CR18","unstructured":"Centraal Bureau voor de Statistiek (CBS). Weging gezondheidsenqu\u00eate 2014, https:\/\/www.cbs.nl\/-\/media\/_pdf\/2019\/18\/weging-gezondheidsenquete-2014-2019ep09.pdf (2019)."},{"key":"72084_CR19","unstructured":"European Commission. Quality report of the second wave of the European Health Interview survey, https:\/\/ec.europa.eu\/eurostat\/documents\/7870049\/8920155\/KS-FT-18-003-EN-N.pdf\/eb85522d-bd6d-460d-b830-4b2b49ac9b03 (2018)."},{"key":"72084_CR20","unstructured":"Ministerie van Volksgezondheid Welzijn en Sport. Directie Zorgverzekeringen. VWS- Verzekerdenmonitor 2017, https:\/\/www.rijksoverheid.nl\/binaries\/rijksoverheid\/documenten\/rapporten\/2017\/11\/21\/vws-verzekerdenmonitor-2017\/vws-verzekerdenmonitor-2017.pdf (2017)."},{"key":"72084_CR21","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment https:\/\/www.whocc.no\/filearchive\/publications\/1_2013guidelines.pdf (2013)."},{"key":"72084_CR22","unstructured":"Zorginstituut Nederland. GIP databank. Aantal gebruikers 2013\u20132018 van Pijnstillers https:\/\/www.gipdatabank.nl\/databank?infotype=g&label=00-totaal&tabel=85_pij&geg=gebr&item=bijlage (2020)."},{"key":"72084_CR23","unstructured":"The Centers for Medicare and Medicaid Services (CMS) and the National Center for Health Statistics (NCHS). ICD-10-CM Official Guidelines for Coding and Reporting FY 2019, https:\/\/www.cdc.gov\/nchs\/icd\/data\/10cmguidelines-FY2019-final.pdf (2019)."},{"key":"72084_CR24","unstructured":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Opioid-related hospital stays among women in the United States, 2016, https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538344\/ (2016)."},{"key":"72084_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2016","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer-Verlag, Berlin, 2016)."},{"key":"72084_CR26","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.3399\/bjgp14X677815","volume":"64","author":"AR Koffeman","year":"2014","unstructured":"Koffeman, A. R. et al. High-risk use of over-the-counter non-steroidal anti-inflammatory drugs: a population-based cross-sectional study. Br. J. Gen. Pract. 64, e191-198. https:\/\/doi.org\/10.3399\/bjgp14X677815 (2014).","journal-title":"Br. J. Gen. Pract."},{"key":"72084_CR27","unstructured":"Instituut Verantwoord Medicijngebruik (IVM). Centraal Bureau Drogisterijbedrijven (CBD). Consument onderschat risico\u2019s pijnstillers, https:\/\/www.drogistensite.nl\/nieuws\/detail\/consument-onderschat-risico-s-pijnstillers (2017)."},{"key":"72084_CR28","unstructured":"Instituut Verantwoord Medicijngebruik (IVM). Centraal Bureau Drogisterijbedrijven (CBD). Pijnstillers: gebruik, kennis en handelingen, https:\/\/eenvandaag.avrotros.nl\/fileadmin\/user_upload\/PDF\/Rapport_IVM_Pijnpeiling.pdf (2018)."},{"key":"72084_CR29","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4103\/0976-500X.77104","volume":"2","author":"AP Gor","year":"2011","unstructured":"Gor, A. P. & Saksena, M. Adverse drug reactions of nonsteroidal anti-inflammatory drugs in orthopedic patients. J. Pharmacol. Pharmacother. 2, 26\u201329. https:\/\/doi.org\/10.4103\/0976-500X.77104 (2011).","journal-title":"J. Pharmacol. Pharmacother."},{"key":"72084_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.0306-5251.2001.01220.x","volume":"53","author":"L Mellemkjaer","year":"2002","unstructured":"Mellemkjaer, L. et al. Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark. Br. J. Clin. Pharmacol. 53, 173\u2013181. https:\/\/doi.org\/10.1046\/j.0306-5251.2001.01220.x (2002).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"72084_CR31","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1001\/archinte.1986.00360210059009","volume":"146","author":"MJ McFarlane","year":"1986","unstructured":"McFarlane, M. J., Feinstein, A. R. & Wells, C. K. Necropsy evidence of detection bias in the diagnosis of lung cancer. Arch. Intern. Med. 146, 1695\u20131698 (1986).","journal-title":"Arch. Intern. Med."},{"key":"72084_CR32","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","volume":"67","author":"L Scholl","year":"2018","unstructured":"Scholl, L., Seth, P., Kariisa, M., Wilson, N. & Baldwin, G. Drug and opioid-involved overdose deaths\u2014United States, 2013\u20132017. MMWR Morb. Mortal. Wkly. Rep. 67, 1419\u20131427. https:\/\/doi.org\/10.15585\/mmwr.mm675152e1 (2018).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"72084_CR33","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug-related deaths and mortality in Europe: update from the EMCDDA expert network, https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/11485\/20193286_TD0319444ENN_PDF.pdf (2019)."},{"key":"72084_CR34","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ejp.1337","volume":"23","author":"C Bosetti","year":"2019","unstructured":"Bosetti, C. et al. Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990\u20132016. Eur. J. Pain 23, 697\u2013707. https:\/\/doi.org\/10.1002\/ejp.1337 (2019).","journal-title":"Eur. J. Pain"},{"key":"72084_CR35","doi-asserted-by":"publisher","first-page":"102616","DOI":"10.1016\/j.drugpo.2019.102616","volume":"76","author":"H Alho","year":"2020","unstructured":"Alho, H. et al. Opioid-related deaths in Europe: Strategies for a comprehensive approach to address a major public health concern. Int. J. Drug Policy 76, 102616. https:\/\/doi.org\/10.1016\/j.drugpo.2019.102616 (2020).","journal-title":"Int. J. Drug Policy"},{"key":"72084_CR36","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1515\/sjpain-2018-0307","volume":"19","author":"AE Muller","year":"2019","unstructured":"Muller, A. E., Clausen, T., Sj\u00f8gren, P., Odsbu, I. & Skurtveit, S. Prescribed opioid analgesic use developments in three Nordic countries, 2006\u20132017. Scand. J. Pain 19, 345. https:\/\/doi.org\/10.1515\/sjpain-2018-0307 (2019).","journal-title":"Scand. J. Pain"},{"key":"72084_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/ejp.1291","volume":"23","author":"C Chenaf","year":"2019","unstructured":"Chenaf, C. et al. Prescription opioid analgesic use in France: Trends and impact on morbidity\u2013mortality. Eur. J. Pain 23, 124\u2013134. https:\/\/doi.org\/10.1002\/ejp.1291 (2019).","journal-title":"Eur. J. Pain"},{"key":"72084_CR38","unstructured":"National Institute for Health and Care Excellence. Medicines optimisation in chronic pain (Key therapeutic topic No. KTT21), https:\/\/www.nice.org.uk\/advice\/ktt21\/chapter\/Evidence-context (2017)."},{"key":"72084_CR39","unstructured":"The Danish Health Authority. National Clinical Guideline on Opioid Treatment of Chronic Non-Malignant Pain, https:\/\/www.sst.dk\/-\/media\/Udgivelser\/2018\/NKR-opioid\/EN\/Quick-Guide-NKR-opioidbehandling-EN.ashx?la=da&hash=496B5DE2B0792DDFFEF65E159C69874786BDBCA1 (2018)."},{"key":"72084_CR40","unstructured":"Taylor, S. et al. Dependence and Withdrawal Associated with Some Prescribed Medicines: An Evidence Review, https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/829777\/PHE_PMR_report.pdf (2019)."},{"key":"72084_CR41","doi-asserted-by":"publisher","first-page":"e225","DOI":"10.3399\/bjgp18X695057","volume":"68","author":"L Mordecai","year":"2018","unstructured":"Mordecai, L., Reynolds, C., Donaldson, L. J. & de C Williams, A. C. Patterns of regional variation of opioid prescribing in primary care in England: A retrospective observational study. Br. J. Gen. Pract. 68, e225\u2013e233. https:\/\/doi.org\/10.3399\/bjgp18X695057 (2018).","journal-title":"Br. J. Gen. Pract."},{"key":"72084_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s40801-019-00163-w","volume":"6","author":"SK Nissen","year":"2019","unstructured":"Nissen, S. K., Potteg\u00e5rd, A. & Ryg, J. Trends of opioid utilisation in Denmark: A nationwide study. Drugs Real World Outcomes 6, 155\u2013164. https:\/\/doi.org\/10.1007\/s40801-019-00163-w (2019).","journal-title":"Drugs Real World Outcomes"},{"key":"72084_CR43","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1177\/0018726708094863","volume":"61","author":"Y Baruch","year":"2008","unstructured":"Baruch, Y. & Holtom, B. C. Survey response rate levels and trends in organizational research. Hum. Relat. 61, 1139\u20131160. https:\/\/doi.org\/10.1177\/0018726708094863 (2008).","journal-title":"Hum. Relat."},{"key":"72084_CR44","unstructured":"National Institute for Health and Care Excellence. Neuropathic pain in adults: pharmacological management in non-specialist settings (NICE Clinical Guideline No. 173), https:\/\/www.nice.org.uk\/guidance\/cg173 (2013)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72084-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72084-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72084-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T18:51:18Z","timestamp":1670352678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-72084-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["72084"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-72084-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"20 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors have completed the Conflict of Interest Statement form and declare: no support from any organisation for the submitted work; AD has received research grants and personal fees from MSD, grants from Medasense, grants from Grunenthal, personal fees from Trevena, grants from AMO, grants from CHDR, outside the submitted work, DOMK has received personal fees from Metabolon, Inc., outside the submitted work; no other relationships or activities that could appear to have influenced the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15309"}}